Earnings summaries and quarterly performance for SiriusPoint.
Executive leadership at SiriusPoint.
Scott Egan
Detailed
Chief Executive Officer
CEO
AS
Anthony Shapella
Detailed
Group Chief Underwriting Officer
DG
David Govrin
Detailed
Group President and Chief Executive Officer of Global Reinsurance
JM
James McKinney
Detailed
Chief Financial Officer
RG
Rob Gibbs
Detailed
Chief Executive Officer, SiriusPoint International
Board of directors at SiriusPoint.
BM
Bronek Masojada
Detailed
Chair of the Board
DL
Daniel Loeb
Detailed
Director
FM
Franklin Montross IV
Detailed
Independent Director
JR
Jason Robart
Detailed
Independent Director
MH
Martin Hudson
Detailed
Independent Director
MM
Mehdi Mahmud
Detailed
Independent Director
PT
Peter Tan
Detailed
Director
SL
Sharon Ludlow
Detailed
Independent Director
SC
Susan Cross
Detailed
Independent Director
Research analysts who have asked questions during SiriusPoint earnings calls.
Andrew Andersen
Jefferies
6 questions for SPNT
Also covers: ACGL, AFG, AHL +21 more
Michael Phillips
Oppenheimer & Co. Inc.
6 questions for SPNT
Also covers: ACIC, AII, CINF +10 more
AM
Anthony Mottolese
Dowling & Partners
4 questions for SPNT
Also covers: GBLI, GLRE
Randy Binner
B. Riley Securities
4 questions for SPNT
Also covers: ARR, BRSP, BUR +14 more
Mitchell Rubin
Raymond James
2 questions for SPNT
Also covers: ACIC, AII, EVER +1 more
Recent press releases and 8-K filings for SPNT.
SiriusPoint's Fitch Ratings Upgraded
SPNT
Earnings
New Projects/Investments
- Fitch Ratings has upgraded the Insurer Financial Strength (IFS) rating of SiriusPoint's operating subsidiaries to 'A' (Strong) from 'A-'.
- SiriusPoint's Long-Term Issuer Default Rating (IDR) was upgraded to 'BBB+' from 'BBB', and its senior debt rating to 'BBB' from 'BBB-', with a Stable Rating Outlook.
- The upgrade reflects strong and improved earnings from solid underwriting profitability, a reduced risk profile following strategic repositioning, strengthened capitalization, and improved shareholders' equity.
- CEO Scott Egan noted that this recognition follows a strong full-year 2025 performance.
3 days ago
SiriusPoint Reports Strong Q4 and Full Year 2025 Results, Announces Share Buyback and Debt Redemption
SPNT
Earnings
Share Buyback
M&A
- SiriusPoint reported a 49% increase in operating earnings per share and 28% growth in diluted book value per share for the full year 2025. The company achieved an operating return on equity of 16.2% for the full year and 17.1% for Q4 2025, both exceeding its 12%-15% target.
- Underwriting results were strong, with a full-year core attritional combined ratio of 91.6%, a 1.5-point improvement over the prior year, and a Q4 2025 core combined ratio of 92.9%. This marks the 19th consecutive quarter of favorable prior year development.
- The company announced a $100 million common share buyback intention over the next 12 months and plans to fully redeem $200 million of 8% preference shares, which will reduce its leverage ratio to an all-time low of 23% by the end of February.
- Gross written premiums grew 16% for the full year and 18% in Q4 2025, significantly driven by the Accident and Health business, which grew 23% in 2025 to approximately $1 billion. The company also completed the sale of Armada MGA for $250 million and announced the sale of Arcadian MGA, crystallizing $390 million in liquidity.
Feb 19, 2026, 1:30 PM
SiriusPoint Reports Strong FY 2025 Earnings and Announces Share Repurchase
SPNT
Earnings
Share Buyback
M&A
- SiriusPoint reported strong financial results for FY 2025, with net income of $444 million, a 141% increase from FY 2024, and Operating Earnings Per Share of $2.55. For Q4 2025, Operating EPS was $0.70.
- The company achieved a Core Combined Ratio of 91.7% for FY 2025 and 92.9% for Q4 2025, marking thirteen consecutive quarters of underwriting profit. Gross Written Premium grew 16% in FY 2025 to $3,689 million and 18% in Q4 2025 to $897 million.
- SiriusPoint's Operating Return on Equity improved to 16.2% in FY 2025, up 1.6 percentage points, and Book Value Per Diluted Share (ex. AOCI) grew by $4.01 (+28%) in 2025 to $18.10.
- Strategic actions included the completion of Armada's sale in Q4 2025, contributing a $222 million gain, and the announcement of an intent to repurchase $100 million of common shares over the next 12 months. The company also reduced its leverage ratio to 28.1% at Q4 2025.
Feb 19, 2026, 1:30 PM
SiriusPoint Reports Strong Q4 and Full Year 2025 Results, Announces Share Buyback and Preference Share Redemption
SPNT
Earnings
Share Buyback
M&A
- SiriusPoint reported a 49% increase in operating earnings per share and a 16.2% operating return on equity for the full year 2025, exceeding its 12%-15% target. Net income for 2025 increased 141% to $444 million.
- The company's top line grew 16% for the full year 2025, with core gross written premiums increasing 18% in Q4 2025. Diluted book value per share grew 28% for the full year.
- SiriusPoint announced plans to redeem $200 million of 8% preference shares, which will reduce its leverage ratio to an all-time low of 23% by the end of February.
- The company also intends to repurchase $100 million of its outstanding common shares over the next twelve months, representing over 4% of total shares outstanding.
- Strategic actions included the sale of Armada MGA and the announced sale of Arcadian MGA, crystallizing $390 million in liquidity. The company continues to prioritize growth in its insurance business, which saw gross written premiums increase 26% in 2025.
Feb 19, 2026, 1:30 PM
SiriusPoint Reports Strong Q4 and Full-Year 2025 Results with Significant Capital Actions
SPNT
Earnings
Share Buyback
M&A
- SiriusPoint reported a strong financial performance for full-year 2025, with operating return on equity of 16.2% (exceeding its 12%-15% target) and diluted book value per share growth of 28%. Operating earnings per share increased 49% year-over-year, reaching $310 million in operating income.
- The company demonstrated significant capital management, announcing a $100 million common share repurchase program and reducing its leverage ratio to an all-time low of 23% by redeeming $200 million in preference shares.
- Top-line growth was robust, with core gross written premiums increasing 16% for the full year and 18% in Q4 2025, largely driven by 23% growth in the Accident and Health segment. Strategic moves included the sale of two MGAs for $390 million in liquidity and acquisitions to bolster its Accident and Health business, with IMG projected to generate over $35 million of EBITDA in 2026.
Feb 19, 2026, 1:30 PM
SiriusPoint Reports Strong Q4 and Full Year 2025 Financial Results
SPNT
Earnings
Share Buyback
New Projects/Investments
- SiriusPoint reported net income available to common shareholders of $240 million ($1.97 per diluted common share) for Q4 2025 and $444 million ($3.64 per diluted common share) for the full year 2025.
- The company achieved an annualized return on equity of 44.9% and an operating return on equity of 17.1% for Q4 2025, with full-year 2025 figures of 22.1% and 16.2% respectively.
- Gross written premium growth was 18% in Q4 2025 and 16% for the full year 2025, alongside a Core combined ratio of 92.9% in Q4 2025 and 91.7% for the full year.
- SiriusPoint announced its intent to repurchase $100 million of common shares over the next 12 months and expects its leverage ratio to drop to 23% post Series B Preference Share redemption.
Feb 18, 2026, 9:19 PM
SiriusPoint Reports Strong Q4 and Full Year 2025 Results
SPNT
Earnings
Share Buyback
Delisting/Listing Issues
- SiriusPoint reported net income available to common shareholders of $240 million for Q4 2025 and $444 million for the full year 2025.
- The company achieved an annualized return on equity of 44.9% and an operating return on equity of 17.1% for Q4 2025, with full-year operating earnings per share increasing 49% to $2.55.
- Gross written premium grew 18% in Q4 2025 and 16% for the full year 2025, alongside a full-year Core combined ratio of 91.7%.
- Book value per diluted common share (ex. AOCI) increased to $18.10 as of December 31, 2025, representing a 23.6% increase from December 31, 2024.
- SiriusPoint announced the redemption of all Series B Preference Shares, which is expected to reduce the leverage ratio to a historic low of 23%, and plans to repurchase $100 million of common shares over the next 12 months.
Feb 18, 2026, 9:10 PM
SiriusPoint's IMG Subsidiary to Acquire World Nomads
SPNT
M&A
New Projects/Investments
- SiriusPoint Ltd. announced that its wholly-owned subsidiary, International Medical Group (IMG), will acquire World Nomads, a global travel insurance and lifestyle brand from nib Group.
- World Nomads contributes approximately $40 million of gross written premium and expands IMG's global distribution to include Australia, Brazil, and Canada.
- This acquisition, combined with the recent acquisition of Assist America (which produces $20 million in annual assistance revenues), is expected to be accretive to both return on equity and earnings per share for SiriusPoint.
- The initial closing for the majority of the World Nomads business is projected for the second or third quarter of 2026, with a final closing in the second half of 2027.
Feb 12, 2026, 9:21 PM
SiriusPoint to Redeem Series B Preference Shares
SPNT
Delisting/Listing Issues
- SiriusPoint Ltd. announced the redemption of all 8 million of its 8.00% Resettable Fixed Rate Preference Shares, Series B.
- The redemption will occur on February 26, 2026, at a price of $25.00 per share plus $0.49 in unpaid, accrued cumulative dividends.
- This action is intended to simplify and optimize the Company's capital structure and financial leverage, and to eliminate the cost of capital associated with these shares.
- Following the redemption, the Series B Preference Shares will be delisted from the New York Stock Exchange and deregistered.
Jan 29, 2026, 10:21 PM
SiriusPoint to Redeem Series B Preference Shares
SPNT
Delisting/Listing Issues
Dividends
Share Buyback
- SiriusPoint Ltd. (NYSE: SPNT) announced it will redeem all 8 million of its outstanding 8.00% Resettable Fixed Rate Preference Shares, Series B.
- The redemption is scheduled for February 26, 2026, at a price of $25.00 per share plus $0.49 in accrued cumulative dividends.
- Following the redemption, these Series B Preference Shares will be delisted from the New York Stock Exchange and deregistered, aiming to simplify and optimize the company's capital structure and eliminate associated costs.
Jan 29, 2026, 10:20 PM
Quarterly earnings call transcripts for SiriusPoint.
Ask Fintool AI Agent
Get instant answers from SEC filings, earnings calls & more